El riesgo de linfoma asociado con el factor de necrosis combinación anti-tumoral y la terapia inmunomodulador para el tratamiento de la enfermedad de Crohn: un meta-análisis

Categoría Resumen estructurado de revisiones sistemáticas
RevistaDatabase of Abstracts of Reviews of Effects (DARE)
Año 2010
Cargando información sobre las referencias

CRD SUMMARY:

The authors concluded that anti-tumour necrosis factor agents combined with immunomodulators was associated with an increased risk of non-Hodgkin's lymphoma in adult patients with Crohn's Disease, but that the absolute risk of these events was low. Given the uncertain quality of included studies, and potential concerns about their synthesis, the extent to which the authors' conclusion is reliable is unclear.
Epistemonikos ID: 3d41611a11f85e172a52aca0e4e78e9e2345b469
First added on: Jun 08, 2012